Skip to main content

August 3, 2017

Welcome Dr. Matthew Billard to CBP! Matthew joins the CBP Executive Leadership team as the Director of Research.

Matt received his PhD in Immunology from M.D. Anderson, Houston and is an accomplished bench-scientist who has received numerous awards and honors throughout his career. Most recently, he has been working in the Thurston Arthritis Research Center, with Dr. Terri Tarrant, exploring the role of GRK3 as a regulator of inflammation in cancer and within the bone marrow.

June 5, 2017

Collaboration between Zylka, Major, and Emanuele labs identifies link between autism gene and Wnt signaling

The labs of Mark Zylka, Ben Major, both in the Dept. of Cell Biology and Physiology, and Mike Emanuele identified a link between the E3 ubiquitin ligase Ube3a, the proteasome, and Wnt signaling. This collaboration harnessed the Zylka labs expertise at studying an autism-linked Ube3a mutation, the Major labs expertise with proteomics and Wnt signaling, and the Emanuele's lab expertise at identifying ubiquitinated substrates.

Vicki Bartsch receives individual predoctoral nrsa

May 4, 2017

Vicki Bartsch receives Individual Predoctoral NRSA

Vicki Bartsch received an F31 individual predoctoral NRSA entitled "Diacylglycerol kinase mediates receptor signaling by regulating lipid levels in somatosensory neurons". The research project is an investigation of a class of enzymes called diacylglycerol kinases that are found at high levels in peripheral pain-sensing neurons. Through this research, she hopes to characterize how diacylglycerol kinases contribute to pain and itch signaling on the molecular and behavioral levels to serve the long-term goal of identifying new targets for chronic pain and itch treatments.